...3) Neither their PCR nor their serology assays had established diagnostic sensitivity. In fact, they were unable to detect the virus in infected samples that the WPI sent them.
While other points may seem to be narrow technical arguments, this is a fundamental weakness in design and conception of the negative studies. They tried to substitute artificial samples for clinical samples from infected humans to validate their assays. This is a major logical fallacy, forced by the belief that no infected humans exist. Since there are healthy people with infections, this does not require acceptance of anything concerning CFS.
As for the samples WPI sent to the CDC, those were split. We haven't heard officially from the others in that investigation. Stay tuned!
-----
There appear to be many afraid the CDC will get off the hook on this one. I ask you to note who was at the press conference: not Reeves, not Switzer, not Ungar, but Steve Munroe, director of the division of high consequence pathogens. When things blow up four or five levels in a hierarchy, and someone from mahogany row has to take a public drubbing, you can be pretty sure the organization is aware that someone screwed up.
Considering the number of nasty surprises for the CDC group looming in the near future, it will be very interesting to watch the fancy footwork from here on.